June 20, 2024

Cardiovascular Health Supplements Market Size, Share, Report 2033

The global cardiovascular health supplements market size accounted for US$ 11.2 billion in 2023 and is projected to reach around USD 24.07 billion by 2033, growing at a CAGR of 8% from 2024 to 2033.

Cardiovascular Health Supplements Market Size 2024 to 2033

Key Points

  • Asia Pacific dominated the market while contributing 39% market share in 2023.
  • By type, in 2023, the natural supplements segment dominated the market with a 70% market share.
  • By type, the synthetic supplements segment is expected to experience substantial growth at a CAGR of 8.13% during the forecast period.
  • By ingredient, in 2023, the omega fatty acids segment dominated the market with a 31% market share.
  • By ingredient, the herbs & botanicals segment is expected to grow at a CAGR of 10.34 during the forecast period.
  • By form, the softgel segment dominated the market holding the largest share, 37%, in 2023.
  • By form, the capsules segment is expected to grow at a CAGR of 9.95% during the forecast period.
  • By distribution channel, the offline segment held the largest market share of 71% in 2023.
  • By distribution channel, the online segment is observed to grow at a CAGR of 10.42% during the forecast period.

Report Summary

The global cardiovascular health supplements market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the cardiovascular health supplements market across the globe.

A comprehensive estimate on the cardiovascular health supplements market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of cardiovascular health supplements during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3790

Cardiovascular Health Supplements Market Scope

Report CoverageDetails
Growth Rate from 2024 to 2033CAGR of 8%
Global Market Size in 2023USD 11.2 Billion
Global Market Size by 2033USD 24.07 Billion
Largest MarketAsia Pacific
Base Year2023
Forecast Period2024 to 2033
Segments CoveredBy Type, By Form, and By Distribution Channel
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized cardiovascular health supplements market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Cybersecurity Mesh Market Size to Attain USD 8.48 Bn by 2033

Market Players

The report includes the profiles of key cardiovascular health supplements market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Recent Developments

  • In September 2023, Nutrartis, a health solutions provider, introduced Cardiosmile, a supplement containing natural plant sterols, in the U.S. The liquid format offers a convenient way to support daily heart health and manage cholesterol.
  • In March 2023, Life Extension, a neutraceuticals company, launched new omega-3 fish oil-based gummy bites. These sugar-free, tropical fruit-flavored chews provide potent omega-3 acids, with a high concentration of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) fatty acids in each serving.

Cardiovascular Health Supplements Market Companies

  • NOW Health Group, Inc.
  • Bright Lifecare Pvt Ltd (Truebasics.com)
  • Natural Organics, Inc.
  • DaVinci Laboratories of Vermont
  • Nordic Naturals
  • Thorne HealthTech, Inc.
  • Nestle (Pure Encapsulations, LLC.)
  • Amway
  • InVite Health
  • GNC Holdings, LLC

Segments Covered in the Report

By Type

  • Natural Supplements
  • Synthetic Supplements
  • Ingredient Outlook (Revenue, USD Million, 2018 – 2030)
  • Vitamins & Minerals
  • Herbs & Botanicals
  • Omega Fatty Acids
  • Coenzyme Q10 (CoQ10)
  • Others

By Form

  • Liquid
  • Tablet
  • Capsules
  • Softgels
  • Powder
  • Others

By Distribution Channel 

  • Offline
  • Online

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cardiovascular Health Supplements Market 

5.1. COVID-19 Landscape: Cardiovascular Health Supplements Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cardiovascular Health Supplements Market, By Type

8.1. Cardiovascular Health Supplements Market Revenue and Volume, by Type, 2024-2033

8.1.1 Natural Supplements

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Synthetic Supplements

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Ingredient Outlook (Revenue, USD Million, 2018 – 2030)

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Vitamins & Minerals

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Herbs & Botanicals

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

8.1.6. Omega Fatty Acids

8.1.6.1. Market Revenue and Volume Forecast (2021-2033)

8.1.7. Coenzyme Q10 (CoQ10)

8.1.7.1. Market Revenue and Volume Forecast (2021-2033)

8.1.8. Others

8.1.8.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Cardiovascular Health Supplements Market, By Form

9.1. Cardiovascular Health Supplements Market Revenue and Volume, by Form, 2024-2033

9.1.1. Liquid

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Tablet

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Capsules

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

9.1.4. Softgels

9.1.4.1. Market Revenue and Volume Forecast (2021-2033)

9.1.5. Powder

9.1.5.1. Market Revenue and Volume Forecast (2021-2033)

9.1.6. Others

9.1.6.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Cardiovascular Health Supplements Market, By Distribution Channel 

10.1. Cardiovascular Health Supplements Market Revenue and Volume, by Distribution Channel, 2024-2033

10.1.1. Offline

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Online

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Cardiovascular Health Supplements Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.1.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.1.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.1.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.1.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.1.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.1.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.2.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.2.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.2.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.2.6.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.2.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.2.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.3.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.3.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.3.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.3.6.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.3.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.3.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.4.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.4.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.6.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.4.6.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.4.7.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.4.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.5.4.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.5.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

11.5.5.2. Market Revenue and Volume Forecast, by Form (2021-2033)

11.5.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

Chapter 12. Company Profiles

12.1. NOW Health Group, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Bright Lifecare Pvt Ltd (Truebasics.com)

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Natural Organics, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. DaVinci Laboratories of Vermont

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Nordic Naturals

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Thorne HealthTech, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Nestle (Pure Encapsulations, LLC.)

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Amway

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. InVite Health

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. GNC Holdings, LLC

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com